Cargando…
Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors
N-methyl-D-aspartate receptors (NMDARs) are an essential target for the analgetic action of tricyclic antidepressants (TCAs). Their therapeutic blood concentrations achieve 0.5–1.5 μM, which, however, are insufficient to cause in vitro the open-channel block known as the only effect of TCAs on NMDAR...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882908/ https://www.ncbi.nlm.nih.gov/pubmed/35237149 http://dx.doi.org/10.3389/fphar.2021.815368 |
_version_ | 1784659798438969344 |
---|---|
author | Stepanenko, Yulia D. Sibarov, Dmitry A. Shestakova, Natalia N. Antonov, Sergei M. |
author_facet | Stepanenko, Yulia D. Sibarov, Dmitry A. Shestakova, Natalia N. Antonov, Sergei M. |
author_sort | Stepanenko, Yulia D. |
collection | PubMed |
description | N-methyl-D-aspartate receptors (NMDARs) are an essential target for the analgetic action of tricyclic antidepressants (TCAs). Their therapeutic blood concentrations achieve 0.5–1.5 μM, which, however, are insufficient to cause in vitro the open-channel block known as the only effect of TCAs on NMDARs. Whereas structures of amitriptyline (ATL), desipramine (DES), and clomipramine (CLO) are rather similar these compounds manifest different therapeutic profiles and side effects. To study structure-activity relationships of DES and CLO on NMDARs, we measured IC(50)s as a function of extracellular calcium ([Ca(2+)]) and membrane voltage (V(m)) of NMDAR currents recorded in cortical neurons. Here two components of TCA action on NMDARs are described, which could be characterized as the Ca(2+)-dependent inhibition and the open-channel block. DES demonstrated a profound Ca(2+)-dependent inhibition of NMDARs, while the CLO effect was weak. DES IC(50) exhibited an e-fold change with a [Ca(2+)] shift of 0.59 mM, which is consistent with ATL. The Ca(2+) dependence of NMDAR inhibition by DES disappeared in BAPTA loaded neurons, suggesting that Ca(2+) acts from the inside. Since CLO differs from DES and ATL by the presence of Cl-atom in the structure, most likely, this is the atom which is responsible for the loss of pronounced [Ca(2+)] dependence. As for the NMDAR open-channel block, both DES and CLO were about 5-folds more potent than ATL due to their slow rates of dissociation either from open and closed states. DES demonstrated stronger V(m)-dependence than CLO, suggesting a deeper location of the DES binding site within the ion pore. Because DES and CLO differ from ATL by the nitrogen-containing tricycle, presumably this moiety of the molecules determines their high-affinity binding with the NMDAR channel, while the aliphatic chain mono-methyl amino-group of DES allows a deep permeation in the channel. Thus, different structure-activity relationships of the Ca(2+)-dependent inhibition and V(m)-dependent open-channel block of NMDARs by DES and CLO suggest that these processes are independent and most likely may represent an action on different molecular targets. The proposed model of TCA action on NMDARs predicts well the experimental values of IC(50)s at physiological [Ca(2+)] and within a wide range of V(m)s. |
format | Online Article Text |
id | pubmed-8882908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88829082022-03-01 Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors Stepanenko, Yulia D. Sibarov, Dmitry A. Shestakova, Natalia N. Antonov, Sergei M. Front Pharmacol Pharmacology N-methyl-D-aspartate receptors (NMDARs) are an essential target for the analgetic action of tricyclic antidepressants (TCAs). Their therapeutic blood concentrations achieve 0.5–1.5 μM, which, however, are insufficient to cause in vitro the open-channel block known as the only effect of TCAs on NMDARs. Whereas structures of amitriptyline (ATL), desipramine (DES), and clomipramine (CLO) are rather similar these compounds manifest different therapeutic profiles and side effects. To study structure-activity relationships of DES and CLO on NMDARs, we measured IC(50)s as a function of extracellular calcium ([Ca(2+)]) and membrane voltage (V(m)) of NMDAR currents recorded in cortical neurons. Here two components of TCA action on NMDARs are described, which could be characterized as the Ca(2+)-dependent inhibition and the open-channel block. DES demonstrated a profound Ca(2+)-dependent inhibition of NMDARs, while the CLO effect was weak. DES IC(50) exhibited an e-fold change with a [Ca(2+)] shift of 0.59 mM, which is consistent with ATL. The Ca(2+) dependence of NMDAR inhibition by DES disappeared in BAPTA loaded neurons, suggesting that Ca(2+) acts from the inside. Since CLO differs from DES and ATL by the presence of Cl-atom in the structure, most likely, this is the atom which is responsible for the loss of pronounced [Ca(2+)] dependence. As for the NMDAR open-channel block, both DES and CLO were about 5-folds more potent than ATL due to their slow rates of dissociation either from open and closed states. DES demonstrated stronger V(m)-dependence than CLO, suggesting a deeper location of the DES binding site within the ion pore. Because DES and CLO differ from ATL by the nitrogen-containing tricycle, presumably this moiety of the molecules determines their high-affinity binding with the NMDAR channel, while the aliphatic chain mono-methyl amino-group of DES allows a deep permeation in the channel. Thus, different structure-activity relationships of the Ca(2+)-dependent inhibition and V(m)-dependent open-channel block of NMDARs by DES and CLO suggest that these processes are independent and most likely may represent an action on different molecular targets. The proposed model of TCA action on NMDARs predicts well the experimental values of IC(50)s at physiological [Ca(2+)] and within a wide range of V(m)s. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882908/ /pubmed/35237149 http://dx.doi.org/10.3389/fphar.2021.815368 Text en Copyright © 2022 Stepanenko, Sibarov, Shestakova and Antonov. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Stepanenko, Yulia D. Sibarov, Dmitry A. Shestakova, Natalia N. Antonov, Sergei M. Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title | Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title_full | Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title_fullStr | Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title_full_unstemmed | Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title_short | Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors |
title_sort | tricyclic antidepressant structure-related alterations in calcium-dependent inhibition and open-channel block of nmda receptors |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882908/ https://www.ncbi.nlm.nih.gov/pubmed/35237149 http://dx.doi.org/10.3389/fphar.2021.815368 |
work_keys_str_mv | AT stepanenkoyuliad tricyclicantidepressantstructurerelatedalterationsincalciumdependentinhibitionandopenchannelblockofnmdareceptors AT sibarovdmitrya tricyclicantidepressantstructurerelatedalterationsincalciumdependentinhibitionandopenchannelblockofnmdareceptors AT shestakovanatalian tricyclicantidepressantstructurerelatedalterationsincalciumdependentinhibitionandopenchannelblockofnmdareceptors AT antonovsergeim tricyclicantidepressantstructurerelatedalterationsincalciumdependentinhibitionandopenchannelblockofnmdareceptors |